Carregant...
Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration
PURPOSE: The aim of this study was to evaluate the effects of switching to ranibizumab in patients with neovascular age-related macular degeneration (nAMD) refractory to aflibercept treatment and to identify predictive factors for switch response. METHODS: A retrospective chart review was conducted...
Guardat en:
| Publicat a: | Graefes Arch Clin Exp Ophthalmol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7375986/ https://ncbi.nlm.nih.gov/pubmed/32399582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00417-020-04730-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|